Park JH - Search Results

1

Correction to Identification of 4-Phenoxyquinoline Based Inhibitors for L1196M Mutant of Anaplastic Lymphoma Kinase by Structure-Based Design.

Mah S, Park JH, Jung HY, Ahn K, Choi S, Tae HS, Jung KH, Rho JK, Lee JC, Passerini CG, Fontana D, Hong SS, Hong S. Mah S, et al. Among authors: park jh. J Med Chem. 2018 Mar 8;61(5):2131. doi: 10.1021/acs.jmedchem.8b00212. Epub 2018 Feb 22. J Med Chem. 2018. PMID: 29470064 No abstract available.

2

HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer.

Rumman M, Jung KH, Fang Z, Yan HH, Son MK, Kim SJ, Kim J, Park JH, Lim JH, Hong S, Hong SS. Rumman M, et al. Among authors: park jh. Oncotarget. 2016 Nov 22;7(47):78029-78047. doi: 10.18632/oncotarget.12871. Oncotarget. 2016. PMID: 27793006 Free PMC article.

3

Tumor vessel normalization by the PI3K inhibitor HS-173 enhances drug delivery.

Kim SJ, Jung KH, Son MK, Park JH, Yan HH, Fang Z, Kang YW, Han B, Lim JH, Hong SS. Kim SJ, et al. Among authors: park jh. Cancer Lett. 2017 Sep 10;403:339-353. doi: 10.1016/j.canlet.2017.06.035. Epub 2017 Jul 6. Cancer Lett. 2017. PMID: 28688971

4

Identification of 4-Phenoxyquinoline Based Inhibitors for L1196M Mutant of Anaplastic Lymphoma Kinase by Structure-Based Design.

Mah S, Park JH, Jung HY, Ahn K, Choi S, Tae HS, Jung KH, Rho JK, Lee JC, Hong SS, Hong S. Mah S, et al. Among authors: park jh. J Med Chem. 2017 Nov 22;60(22):9205-9221. doi: 10.1021/acs.jmedchem.7b01039. Epub 2017 Nov 9. J Med Chem. 2017. PMID: 29091425

5

Radiosensitization of the PI3K inhibitor HS-173 through reduction of DNA damage repair in pancreatic cancer.

Park JH, Jung KH, Kim SJ, Fang Z, Yan HH, Son MK, Kim J, Kang YW, Lee JE, Han B, Lim JH, Hong SS. Park JH, et al. Oncotarget. 2017 Dec 1;8(68):112893-112906. doi: 10.18632/oncotarget.22850. eCollection 2017 Dec 22. Oncotarget. 2017. PMID: 29348875 Free PMC article.

6

HS-1371, a novel kinase inhibitor of RIP3-mediated necroptosis.

Park HH, Park SY, Mah S, Park JH, Hong SS, Hong S, Kim YS. Park HH, et al. Among authors: park jh, park sy. Exp Mol Med. 2018 Sep 20;50(9):1-15. doi: 10.1038/s12276-018-0152-8. Exp Mol Med. 2018. PMID: 30237400 Free PMC article.

7

HS-173 as a novel inducer of RIP3-dependent necroptosis in lung cancer.

Park JH, Jung KH, Kim SJ, Yoon YC, Yan HH, Fang Z, Lee JE, Lim JH, Mah S, Hong S, Kim YS, Hong SS. Park JH, et al. Cancer Lett. 2019 Mar 1;444:94-104. doi: 10.1016/j.canlet.2018.12.006. Epub 2018 Dec 21. Cancer Lett. 2019. PMID: 30583075

8

PBT-6, a Novel PI3KC2γ Inhibitor in Rheumatoid Arthritis.

Kim J, Jung KH, Yoo J, Park JH, Yan HH, Fang Z, Lim JH, Kwon SR, Kim MK, Park HJ, Hong SS. Kim J, et al. Among authors: park jh, park hj. Biomol Ther (Seoul). 2020 Mar 1;28(2):172-183. doi: 10.4062/biomolther.2019.153. Biomol Ther (Seoul). 2020. PMID: 31739383 Free PMC article.

9

Selonsertib Inhibits Liver Fibrosis via Downregulation of ASK1/ MAPK Pathway of Hepatic Stellate Cells.

Yoon YC, Fang Z, Lee JE, Park JH, Ryu JK, Jung KH, Hong SS. Yoon YC, et al. Among authors: park jh. Biomol Ther (Seoul). 2020 Nov 1;28(6):527-536. doi: 10.4062/biomolther.2020.016. Biomol Ther (Seoul). 2020. PMID: 32451370 Free PMC article.

10

ANGPTL4 accelerates KRAS^G12D-Induced acinar to ductal metaplasia and pancreatic carcinogenesis.

Yan HH, Jung KH, Lee JE, Son MK, Fang Z, Park JH, Kim SJ, Kim JY, Lim JH, Hong SS. Yan HH, et al. Among authors: park jh. Cancer Lett. 2021 Oct 28;519:185-198. doi: 10.1016/j.canlet.2021.07.036. Epub 2021 Jul 24. Cancer Lett. 2021. PMID: 34311032

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14,811 results

Search Page